Last filing: Sep 18, 2026. Most recent purchase on record: Dec 29, 2021.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | Director | Jul 25, 2022 | Sep 18, 2026 |
| BridgeBio Pharma, Inc. (BBIO) | Director | Dec 16, 2019 | Jun 24, 2026 |
| Jazz Pharmaceuticals plc (JAZZ) | Former Director | Aug 17, 2007 | Aug 14, 2013 |
| HCA Healthcare (HCA) | Former Director |
Also a director at
BridgeBio Pharma, Inc. (BBIO), Jazz Pharmaceuticals plc (JAZZ) (no filing in the last 18 months), HCA Healthcare (HCA) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 16, 2026, Roivant Sciences Ltd.: 5,054 shares granted. 1 filing: 1
- Sep 10, 2026, Roivant Sciences Ltd.: 2,905 shares withheld by the company for taxes. 1 filing: 1
- Jul 17, 2026, Roivant Sciences Ltd.: 405 shares awarded. 1 filing: 1
- Jun 22, 2026, BridgeBio Pharma, Inc.: 3,990 shares granted. 1 filing: 1
- Apr 17, 2026, Roivant Sciences Ltd.: 469 shares awarded; 94 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.